USFDA gives nod to Alembic Pharma’s generic formulation to treat heart disorder
- Posted on October 21, 2024
- By Financial Express
- 3 Views
USFDA gives nod to Alembic Pharma’s generic formulation to treat heart disorder
Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg, 180 mg, and 240 mg have an estimated market size of US$ 28.2 million for twelve months ending June 2024 according to IQVIA.
